The Government Accountability Office (GAO) has completed a study of the effectiveness of the FDA and in testimony before Congress concluded.
"...these shortcomings in both premarket and postmarket activities raise serious
concerns about FDA's regulation of medical devices."
The highlights to the report to Congress from the GAO can be found here
The full report to Congress can be found here.